NEKO PHARMA
0661.827.337 · rovalta.com · 24/09/2026
NEKO PHARMA
Overview
What does NEKO PHARMA do?
NEKO PHARMA is a Private company with limited liability incorporated in 2016. Its main activity is: Public relations and communication activities. Its registered office is in La Louvière.
7110 La Louvière · WallonieSee on map
Trend over 9 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||
| Gross margin | -4,2 k € | -21.8% | -3,5 k € | +17.2% | -4,2 k € | -5.4% | -4 k € | +10.2% | -4,4 k € | +13.5% | -5,1 k € | -124% | 20,8 k € | -22.2% | 26,7 k € | -85.2% | 180,8 k € |
| EBITDA | -4,3 k € | -23.7% | -3,5 k € | +20.7% | -4,4 k € | -8.5% | -4 k € | +13.0% | -4,6 k € | +10.4% | -5,1 k € | -125% | 20,7 k € | -22.2% | 26,6 k € | -85.3% | 180,7 k € |
| Operating result | -4,3 k € | -23.7% | -3,5 k € | +20.7% | -4,4 k € | -8.5% | -4 k € | +13.0% | -4,6 k € | +10.4% | -5,1 k € | -125% | 20,7 k € | -22.2% | 26,6 k € | -85.1% | 179,3 k € |
| Net result | 29,7 k € | -22.2% | 38,1 k € | +68.3% | 22,7 k € | +3.0% | 22 k € | +210% | 7,1 k € | -79.5% | 34,5 k € | -44.7% | 62,5 k € | +293% | 15,9 k € | -90.2% | 162,6 k € |
| Balance sheet | |||||||||||||||||
| Equity | 413,6 k € | +7.7% | 384 k € | +11.0% | 345,8 k € | +7.0% | 323,2 k € | +7.3% | 301,2 k € | +2.4% | 294,1 k € | +13.3% | 259,5 k € | +31.7% | 197,1 k € | +8.8% | 181,2 k € |
| Total assets | 725,8 k € | -0.7% | 730,7 k € | +0.4% | 727,5 k € | -0.6% | 731,9 k € | -1.4% | 742,2 k € | -3.5% | 769,2 k € | +0.3% | 766,7 k € | +3.3% | 741,9 k € | -6.0% | 789,6 k € |
| Cash | 540,3 € | -87.3% | 4,2 k € | +184% | 1,5 k € | -64.7% | 4,2 k € | -26.3% | 5,7 k € | +56.8% | 3,7 k € | -47.4% | 7 k € | +38.5% | 5 k € | +111% | 2,4 k € |
| Debts | 312,2 k € | -10.0% | 346,7 k € | -9.2% | 381,7 k € | -6.6% | 408,8 k € | -7.3% | 441 k € | -7.2% | 475,2 k € | -6.3% | 507,2 k € | -6.9% | 544,9 k € | -10.4% | 608,5 k € |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 2 ended
Active mandates
Ended mandates
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 26/08/2026 | 27/08/2025 | 30/08/2024 | 27/09/2023 | 29/08/2022 | 31/08/2021 |
| General meeting | 25/06/2026 | 21/06/2025 | 21/06/2024 | 22/06/2023 | 23/06/2022 | 24/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
9 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 25/06/2026 | 26/08/2026 | French | |
| Micro model | 31/12/2024 | 21/06/2025 | 27/08/2025 | French | |
| Micro model | 31/12/2023 | 21/06/2024 | 30/08/2024 | French | |
| Micro model | 31/12/2022 | 22/06/2023 | 27/09/2023 | French | |
| Micro model | 31/12/2021 | 23/06/2022 | 29/08/2022 | French | |
| Micro model | 31/12/2020 | 24/06/2021 | 31/08/2021 | French | |
| Micro model | 31/12/2019 | 04/09/2020 | 30/09/2020 | French | |
| Micro model | 31/12/2018 | 27/06/2019 | 27/08/2019 | French | |
| Abridged model | 31/12/2017 | 28/06/2018 | 29/08/2018 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 250 k€ and 500 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 2 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202529,7 k €↓
- 2024Annual accounts 202438,1 k €↑
- 2023Annual accounts 202322,7 k €↑
- 2022Annual accounts 202222 k €↑
- 2021Annual accounts 20217,1 k €↓
- 2020Annual accounts 202034,5 k €↓
- 2019Annual accounts 201962,5 k €↑
- 2018Annual accounts 201815,9 k €↓
- 2017Annual accounts 2017162,6 k €
- 30/08/2016IncorporationPrivate company with limited liability